Oak Street Health, Inc. (OSH)

SOMERVILLE, Mass.--(BUSINESS WIRE)-- #diabetes--Podimetrics, a leading company specializing in complex diabetes solutions, has announced the appointment of Vin Varma as Chief Experience Officer. Varma is a seasoned executive in consumer experience and operations, recognized for implementing best practices from world-class service organizations into mid and late-stage startups. In his new role at Podimetrics, Varma will oversee patient experience, clinical services, and operational functions throughout the.

CVS Health Corp has been seeking a private equity partner to fund growth at Oak Street Health, a primary care provider it bought a year ago, Bloomberg News reported on Thursday.

Investing is a complex game, but the aim is simple: Profit. Despite there being numerous avenues through which this objective can be achieved, many concentrate on short-term price movement and growth.

DENVER--(BUSINESS WIRE)--Strive Health, a national leader in value-based kidney care, and Oak Street Health, a network of value-based primary care centers for adults on Medicare, have launched a multi-year national collaboration focused on people with stage 4 chronic kidney disease (CKD) through end-stage kidney disease (ESKD) across the 21 states in which Oak Street Health currently operates. The collaboration reflects both organizations' common goal to rebuild and transform healthcare through.

MILL VALLEY, Calif.--(BUSINESS WIRE)--FCPT Announces Acquisition of Five Oak Street Health Properties for $24.3 Million.

CHICAGO--(BUSINESS WIRE)--Oak Street Health, a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced plans to open centers in Little Rock, Arkansas; Des Moines and Davenport, Iowa; Kansas City, Kansas and Richmond, Virginia, beginning this summer. The expansion into these four new states will mark the 25th state in which Oak Street Health serves older adults. Oak Street will also continue to expand into new.

CVS Health is famous for its pharmacies, but these days it's more of a health benefits management business. Shares of CVS Health are down about 30% from a peak the stock reached last summer.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oak Street Health, Inc. (NYSE: OSH) to CVS Health Corporation (NYSE: CVS). Under the terms of the proposed transaction, shareholders of Oak Street will receive $39.00 in cash for each share of Oak Street that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-osh/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oak Street Health, Inc. (NYSE: OSH) to CVS Health Corporation (NYSE: CVS). Under the terms of the proposed transaction, shareholders of Oak Street will receive $39.00 in cash for each share of Oak Street that they own.

CHICAGO--(BUSINESS WIRE)--Oak Street Health, Inc. (NYSE: OSH or “Oak Street Health”), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced its Board of Directors has cancelled its 2023 Annual Meeting of Stockholders scheduled for Thursday, April 27, 2023, at 8:30 A.M., Central Time (the “Annual Meeting”).

CHICAGO--(BUSINESS WIRE)--Oak Street Health, Inc. (NYSE: OSH or “Oak Street Health”), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced its Board of Directors has cancelled its 2023 Annual Meeting of Stockholders scheduled for Thursday, April 27, 2023, at 8:30 A.M., Central Time (the “Annual Meeting”). This follows the previously announced definitive agreement under which CVS Health Corporation (NYSE: CVS or “CVS Health”), a leading health solutions company, will acquire Oak Street Health in an all-cash transaction at $39.00 per share, representing an enterprise value of approximately $10.6 billion. Oak Street Health currently anticipates that the transaction will close in the first half of 2023, subject to customary closing conditions, including approval of the merger by Oak Street Health stockholders. Oak Street Health expects that the current members of its Board of Directors will continue as directors until the closing of the transaction. Upon closing of the transaction, Oak Street Health common stock will no longer be listed on any public market. If the transaction is not completed pursuant to the terms of the merger agreement governing the proposed transaction (the “Merger Agreement”), the Oak Street Health Board of Directors will reschedule the Annual Meeting for a later date. About Oak Street Health, Inc. Founded in 2012, Oak Street Health is a network of value-based primary care centers for adults on Medicare. With a mission of rebuilding healthcare as it should be, Oak Street Health operates an innovative healthcare model focused on quality of care over volume of services and assumes the full financial risk of its patients. Oak Street Health currently operates more than 170 centers across 21 states and is the only primary care provider to carry the AARP name. Oak Street Health is a winner of Energage’s 2022 Top Workplaces USA award, was recognized by Inc. on its inaugural Best-Led Companies of 2021 list and was honored as a recipient of the 2022 and 2021 Joy in Medicine™ Health System Recognition Program by the American Medical Association. To learn more about Oak Street Health’s proven approach to care, visit oakstreethealth.com. Cautionary Statement Regarding Forward-Looking Statements The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Oak Street Health. This press release contains forward-looking statements, which include all statements that do not relate solely to historical or current facts, such as statements regarding Oak Street Health’s expectations, intentions or strategies regarding the future. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “aim,” “potential,” “continue,” “ongoing,” “goal,” “can,” “seek,” “target” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Statements in this press release that are forward looking may include, but are not limited to, statements regarding the expected timing of the closing of the proposed acquisition and other transactions contemplated by the Merger Agreement. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Such risks and uncertainties include, but are not limited to: the occurrence of any event, change or other circumstance that could give rise to the right of Oak Street Health or CVS Health or both of them to terminate the Merger Agreement, including circumstances requiring a party to pay the other party a termination fee pursuant to the Merger Agreement; the failure to obtain Oak Street Health stockholder approval in a timely manner or otherwise; the risk that the acquisition may not close in the anticipated timeframe or at all due to one or more of the other closing conditions to the transaction not being satisfied or waived; the risk that there may be unexpected costs, charges or expenses resulting from the proposed acquisition; risks that the proposed transaction disrupts Oak Street Health’s current plans and operations; the risk that certain restrictions during the pendency of the proposed transaction may impact Oak Street Health’s ability to pursue certain business opportunities or strategic transactions; risks related to disruption of each company’s management’s time and attention from ongoing business operations due to the proposed transaction; continued availability of capital and financing and rating agency actions; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Oak Street Health’s common stock, credit ratings or operating results; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Oak Street Health to retain and hire key personnel, to retain customers and to maintain relationships with its business partners, suppliers and customers and on its operating results and businesses generally, including with respect to Humana Inc. and its affiliates, which lease or license to Oak Street Health a majority of Oak Street Health’s primary care centers; the risk of litigation that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers and/or regulatory actions related to the proposed acquisition, including the effects of any outcomes related thereto; risks related to unpredictable and severe or catastrophic events, including but not limited to acts of terrorism, war or hostilities, cyber attacks, or the impact of the COVID-19 pandemic or any other pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide on Oak Street Health’s business, financial condition and results of operations, as well as the response thereto by each company’s management; and other business effects, including the effects of industry, market, economic, political or regulatory conditions. Also, Oak Street Health’s actual results may differ materially from those contemplated by the forward-looking statements for a number of additional reasons as described in Oak Street Health’s filings with the Securities and Exchange Commission (the “SEC”), including those set forth in the Risk Factors section and under any “Forward-Looking Statements” or similar heading in Oak Street Health’s most recently filed Annual Report on Form 10-K and Oak Street Health’s Current Reports on Form 8-K. You are cautioned not to place undue reliance on Oak Street Health’s forward-looking statements. Oak Street Health’s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding CVS Health’s proposed acquisition of Oak Street Health, future events and operating performance, and are applicable only as of the dates of such statements. Oak Street Health assumes no duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. Additional Information and Where to Find It This press release is being made in respect of the proposed transaction involving Oak Street Health and CVS Health. Oak Street Health has filed a definitive proxy statement and a form of proxy card with the SEC in connection with the solicitation of proxies for the special meeting of stockholders of Oak Street Health relating to the proposed transaction (the “Definitive Proxy Statement”). This press release is not a substitute for the Definitive Proxy Statement or any other document that may be filed by Oak Street Health with the SEC. BEFORE MAKING ANY DECISION, OAK STREET HEALTH STOCKHOLDERS ARE URGED TO CAREFULLY READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE INTO THE DEFINITIVE PROXY STATEMENT BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Any vote in respect of resolutions to be proposed at Oak Street Health’s special meeting of stockholders to approve the proposed transaction or other responses in relation to the proposed transaction should be made only on the basis of the information contained in the Definitive Proxy Statement. You may obtain a free copy of the Definitive Proxy Statement and other related documents filed by Oak Street Health and documents filed by CVS Health with the SEC at the website maintained by the SEC at www.sec.gov or by accessing the Investor Relations section of Oak Street Health’s website at https://www.oakstreethealth.com for documents filed by Oak Street Health or the Investors portion of CVS Health’s website at https://investors.cvshealth.com for documents filed by CVS Health. No Offer or Solicitation This press release is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Participants in the Solicitation Oak Street Health, CVS Health and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from Oak Street Health’s stockholders in connection with the proposed transaction. Information regarding CVS Health’s directors and executive officers is contained in CVS Health’s Definitive Proxy Statement for its 2022 Annual Meeting of Stockholders filed with the SEC on April 1, 2022, as updated by CVS Health’s subsequent filings made on www.sec.gov. Information regarding Oak Street Health’s directors and executive officers, including a description of their respective direct or indirect interests, by security holdings or otherwise, is and will be included in the Definitive Proxy Statement and Oak Street Health’s other filings with the SEC made subsequent to the date of the Definitive Proxy Statement. To the extent holdings of Oak Street Health’s securities by such directors or officers have changed or will change since the amounts printed as of a date disclosed in the Definitive Proxy Statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or other ownership reports filed with the SEC. Additional information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, is set forth in the Definitive Proxy Statement and other materials to be filed with the SEC in connection with the special meeting of Oak Street Health’s stockholders. These documents can be obtained free of charge from the SEC’s website at www.sec.gov or by accessing the Investor Relations section of Oak Street Health’s website at https://www.oakstreethealth.com for documents filed by Oak Street Health or the Investors portion of CVS Health’s website at https://investors.cvshealth.com for documents filed by CVS Health.

CVS has piled on debt to reinvent its business. The stock's been sold off in this high-interest-rate environment.

CHICAGO--(BUSINESS WIRE)-- Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, and Interwell Health, a kidney care management company that partners with physicians on its mission to reimagine healthcare, today announced the launch of OakWell, a joint venture that will offer the highest-quality primary care to end-stage kidney disease (ESKD) patients directly in the dialysis center. This unique approach to primary care for ESKD patients aims to reduce hospitalizations, increase kidney transplantations, and improve outcomes to lower the total cost of care. When a patient receives in-center dialysis treatment, they spend around 12 hours each week in a dialysis center, often making it difficult to attend primary care and other healthcare appointments. This is a significant challenge, as dialysis patients often have other complex chronic conditions and would benefit from high-quality, preventive primary care. OakWell enables patients to receive coordinated care from a primary care team and nephrologist. “There is a significant opportunity to leverage the time spent by dialysis patients in-center to improve their overall quality of life,” said Dr. David Buchanan, Chief Clinical Officer at Oak Street Health. “Receiving personalized, preventive primary care from expert care teams can positively impact patient health. We are thrilled to launch this innovative joint venture to remove barriers to comprehensive care for people living with kidney failure.” OakWell will bring the type of coordinated primary care that dialysis patients need directly to them, offering appropriate interventions in the center while still working in close partnership with nephrologists. This will remove the significant barrier of attending additional, separate medical appointments and helping address important issues of health equity. These provider-led teams will coordinate with the dialysis care teams, and other specialists, ensuring the most comprehensive and coordinated concierge-level care. “People living with kidney disease have incredibly complex needs,” said Robert Sepucha, CEO of Interwell Health. “We are uniquely positioned to support these patients and are making great strides through our physician partnerships and connectivity to dialysis centers. We know that value-based care only really works when we transform the whole system, which is why we're so excited to partner with Oak Street Health. Through this collaboration with a leader in primary care, we can truly help dialysis patients live their best lives.” The OakWell care teams will closely manage patients' chronic conditions, help them avoid missed dialysis treatments, quickly reschedule any missed dialysis treatments, and coordinate care outside of the center. When patients have urgent needs and aren't currently in a dialysis center, providers will conduct video visits and provide other support to make sure patients stay healthy and out of the hospital. Additional services such as behavioral health and renal pharmacy support will provide complete, wraparound care. OakWell care teams will also support coordination of kidney transplants when possible. OakWell will initially begin offering care services in Chicago, Houston and Dallas-Fort Worth dialysis centers in Q3 of 2023. OakWell is hiring qualified primary care physicians, nurse practitioners, medical assistants and community health workers. To apply, visit this link. About Oak Street Health Founded in 2012, Oak Street Health is a network of value-based primary care centers for adults on Medicare. With a mission of rebuilding healthcare as it should be, the Company operates an innovative healthcare model focused on quality of care over volume of services, and assumes the full financial risk of its patients. Oak Street Health currently operates more than 170 centers across 21 states and is the only primary care provider to carry the AARP name. The Company is a winner of Energage's 2022 Top Workplaces USA award, was recognized by Inc. on its inaugural Best-Led Companies of 2021 list and was honored as a recipient of the 2022 and 2021 Joy in Medicine™ Health System Recognition Program by the American Medical Association. To learn more about Oak Street Health’s proven approach to care, visit oakstreethealth.com or read its Social Impact Report. About Interwell Health Interwell Health is a kidney care management company that partners with physicians on its mission to reimagine healthcare – with the expertise, compassion, and vision to set the standard for the industry and help patients live their best lives. The company is differentiated by its ability to deliver improved clinical outcomes and better quality of life for patients, reduce the total cost of care for payer partners, and provide the resources physicians need to thrive in a value-based world – all at scale. To learn more, visit interwellhealth.com.

CHICAGO--(BUSINESS WIRE)--Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, and Interwell Health, a kidney care management company that partners with physicians on its mission to reimagine healthcare, today announced the launch of OakWell, a joint venture that will offer the highest-quality primary care to end-stage kidney disease (ESKD) patients directly in the dialysis center.

Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 9.68% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

CHICAGO--(BUSINESS WIRE)--Oak Street Health, Inc. (NYSE: OSH, or the “Company”), a network of value-based primary care centers for adults on Medicare, today reported financial results for the year ended December 31, 2022. “Our team's commitment and hard work delivered outstanding health outcomes and an unmatched patient experience leading to consistent center-level performance and strong full year results.